Company: CSLMF
Filing Date: 2025-05-22
Form Type: PRE 14A
Source: 0001193125-25-125124
Chunk: 23

Company: CSLM ACQUISITION CORP.
Filing Date: 2025-05-22
Form: PRE 14A
Chunk 23
---
akes no obligation to update these forward-looking statements to
reflect events or circumstances after the date of this proxy statement or to reflect the occurrence of unanticipated events.

12

BACKGROUND

The Company

The Company is a blank
check company incorporated in the Cayman Islands as an exempted company. We were incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination
with one or more businesses, which we refer to as our initial business combination.

On January 18, 2022, the Company consummated the
IPO of 18,975,000 units at a price of $10.00 per public unit, including the full exercise of the underwriter’s overallotment option, generating gross proceeds of $189,750,000. Substantially concurrently with the closing of the IPO, the Company
consummated a private placement of 7,942,500 warrants, at a price of $1.00 per private placement warrant to the Sponsor (the “Private Warrants”), generating gross proceeds of $7,942,500.

Upon the closing of the IPO and the underwriters’ exercise of the over-allotment option, and associated private placement, 191,647,500
($10.10 per unit) of cash was placed in the Trust Account with Continental Stock Transfer & Trust Company acting as trustee established for the benefit of the persons holding Public Shares.

On July 13, 2023 as approved by its shareholders at an extraordinary general meeting, the Company’s Existing Charter was amended by
a special resolution approved by the shareholders, and provides that the Sponsor (as hereinafter defined) has the right to cause the Company to extend the period of time to consummate a business combination (the “Combination Period”) on a month-to-month basis, until October 18, by depositing $70,000 (each an “Extension Payment”) into the Trust Account for each one-month extension. In connection with this extraordinary general meeting, 14,202,813 Public Shares were tendered for redemption, leaving 4,772,187 Public Shares outstanding.

On July 13, 2023, the Company issued an aggregate of 4,743,749 shares of its Class A Shares to Consilium Acquisition Sponsor I, LLC,
the Company’s sponsor (the “Sponsor”) and the holder of the Company’s Class B ordinary shares, par value $0.0001 per share (“